ArticleAntimicrobial agents and chemotherapy2026
Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant
Mikaela M Walker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.